Abbott CEO Robert Ford called cancer testing a "critically important market" that the firm has made a priority to move into.

InnotiveDx's UTI diagnostic technology provides bacterial identification and antimicrobial susceptibility test results in less than 60 minutes.

The agency would down-classify nucleic acid-based tests for use with a corresponding approved therapy product to Class II devices from Class III.

The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple companies as well as other in vitro diagnostic tests.

NEW YORK – Agilent Technologies said after the close of the market Monday that its fiscal fourth quarter revenues grew 9 percent year over year. For the three months ended Oct. 31, the Santa Clara, ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – Alzheimer's testing firm C2N Diagnostics said Monday that it has received a laboratory permit from the New York State Department of Health's Clinical Laboratory Evaluation Program (CLEP).

NEW YORK – Siemens Healthineers is planning a flurry of new assay launches in its diagnostics segment for 2026 as it looks to consolidate its portfolio and streamline operations to align with a new ...

The test is expected to be used by payors and healthcare systems to identify people most likely to respond to the weight-loss drugs.

PrognomiQ announced the initial launch of its ProVue blood test while Mercy presented new data detailing the performance of its Halo lung cancer test.

A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.